EPIX Therapeutics

About:

EPIX Therapeutics develops and commercializes microwave radiometry-based products for electrophysiology tests.

Website: http://www.actmed.net

Top Investors: Ajax Health, New Enterprise Associates, Keiretsu Forum, Questa Capital Management, NBGI Ventures

Description:

EPIX Therapeutics develops and manufactures products for use in electrophysiology based on microwave radiometry technology. Its products provide real-time feedback of energy delivered by catheters during cardiac ablation procedures. The company has a strategic relationship with Hansen Medical Inc. Advanced Cardiac Therapeutics, Inc. (ACT), a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), today announced it has changed its name to EPIX Therapeutics, Inc.

Total Funding Amount:

$69M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Laguna Beach, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)actmed.net

Founders:

Duke Rohlen, Eric Kanowsky

Number of Employees:

11-50

Last Funding Date:

2017-05-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai